OR WAIT null SECS
Angie Drakulich was editorial director of Pharmaceutical Technology.
The US Food and Drug Administration launched last week a performance management system designed to advance President Obama's commitment to transparency, public participation, and governmental collaboration.
The US Food and Drug Administration launched last week a performance-management system designed to advance President Obama’s commitment to transparency, public participation, and governmental collaboration. Called FDA-TRACK, the system will monitor more than 100 FDA program offices using data from key performance metrics, according to an agency press release. Data will be gathered monthly, analyzed, and presented each quarter to FDA senior leadership. The system is called FDA-TRACK because the public will be able to view the data on FDA's website and track the agency’s progress in meeting established goals.
“It gives managers and employees a new way to measure their effectiveness in meeting goals to protect the public health and provides a way for the public to monitor agency activities,” said FDA Commissioner Margaret Hamburg in an Aug. 31, 2010, FDA press release.
The system will monitor four areas, according to the release:
On a related note, the agency launched an information-technology system to monitor imports coming across US borders last February.